Lily W. Xu, Ph.D.
Dr. Xu performs patentability and freedom-to-operate analyses and prosecutes patent applications in the fields of biotechnology. Dr. Xu obtained her Ph.D. in Cell and Developmental Biology from Harvard University, where her research revealed a new regulatory mechanism of cell death and inflammation. She has peer reviewed more than 10 manuscripts for scientific journals, including Nature and Cell.
- U.S. Patent and Trademark Office
- W. Zhou, “The Patent Landscape of Genetically Modified Organisms,” Harvard University, Science in the News, 2015
- D. Ofengeim, Y. Ito, A. Najafov, Y. Zhang, B. Shan, J. DeWitt, J. Ye, X. Zhang, A. Chang, H. Vakifahmetoglu-Norberg,, J. Geng, B. Py, W. Zhou, P. Amin, J. Lima, C. Qi, Q. Yu, B. Trapp, J. Yuan, “Activation of necroptosis in Multiple Sclerosis,” Cell Reports, 10(11):1836-49, 2015
- W. Zhou, J. Yuan, “Necroptosis in Development and Disease,” Seminars in Cell and Developmental Biology, 35:14-23, 2014
- W. Zhou, J. Yuan, “Snapshot: Non-Apoptotic Cell Death,” Cell, 158(2):464-464.el., 2014
- A. Degterev, W. Zhou, J. Maki, J. Yuan, “Assays for Necroptosis and Activity of RIP Kinases,” Methods in Enzymology, 545:1-33, 2014
- W. Zhou, J. Yuan, "Cell Biology: Death by Deacetylation,” Nature, 492(7428):194-5, 2012
- D. Christofferson, Y. Li, J. Hitomi, W. Zhou, C. Upperman, H. Zhu, et al., “A Novel Role for RIP1 Kinase in Meditating TNF Production,” Cell Death and Disease, 3:e320, 2012
- M. Lipinski, G. Hoffman, A. Ng, W. Zhou, B. Py, E. Hsu, et al., “A Genome-Wide siRNA Screen Reveals Multiple mTORC1 Independent Signaling Pathways Regulating Autophagy Under Normal Nutritional Conditions,” Developmental Cell, 18(6):1041-52, 2010
28 State StreetSuite 700Boston, MA 02109
Harvard University, Ph.D., Cell and Developmental Biology, 2015
Tsinghua University, B.S., Chemistry and Biology, 2007